Discounting role in cost-effectiveness of HPV vaccination by Starkie Camejo et al. (Public Health Vol 129(7):989-92)

Public Health. 2016 Mar:132:108-9. doi: 10.1016/j.puhe.2015.10.038. Epub 2015 Dec 22.

Authors

Thomas Butt¹, Rosybel Drury², Nathalie Largeron²

Affiliations

¹ Sanofi Pasteur MSD, Maidenhead, United Kingdom. Electronic address: thomas.butt.10@ucl.ac.uk.
² Sanofi Pasteur MSD, Lyon, France.

PMID: 26725592
DOI: 10.1016/j.puhe.2015.10.038

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost-Benefit Analysis / methods*
Early Detection of Cancer / economics*
Female
Humans
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / economics*
Uterine Cervical Neoplasms / prevention & control*

Substances

Papillomavirus Vaccines